Literature DB >> 8148733

Fluoroquinolones in upper respiratory tract infections.

M Spiteri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8148733      PMCID： PMC2539729          DOI： 10.1136/bmj.308.6929.657c

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa.

Authors:  M Powell; D McVey; M H Kassim; H Y Chen; J D Williams
Journal:  J Antimicrob Chemother       Date:  1991-08       Impact factor: 5.790

2.  Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections.

Authors:  R J Körner; D S Reeves; A P MacGowan
Journal:  BMJ       Date:  1994-01-15

3.  Treatment of acute exacerbations of chronic obstructive airways disease--a comparison of amoxycillin and ciprofloxacin.

Authors:  G S Basran; J Joseph; A M Abbas; C Hughes; G S Tillotson
Journal:  J Antimicrob Chemother       Date:  1990-12       Impact factor: 5.790

4.  Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis.

Authors:  R T Bachand
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.